Pharmaceutical care for patients with leprosy: impact on treatment adherence and pharmacotherapy safety

Leprosy, also known as Hansen's disease, is a chronic infection caused by a specific type of bacteria that targets the nerves and skin. While the disease can lead to severe physical disability and carries a heavy social stigma that has persisted for centuries, it is entirely curable with a combination of three antibiotics taken over a long period. This treatment, known as multidrug therapy, is provided free of charge in many parts of the world, yet a significant problem remains: many patients stop taking their medicine before they are fully cured. The reasons for this are complex, ranging from the unpleasant side effects of the drugs to the difficulty of remembering to take pills for months or even years. When patients stop early, the bacteria can return, sometimes stronger and resistant to the medicine, which puts the entire community at risk.

A recent systematic review conducted by researchers in Brazil sought to understand how clinical pharmacists can help solve this problem. The team analyzed existing scientific studies to see if having a pharmacist actively involved in a patient's care—rather than just handing out medicine—could improve how well patients stick to their treatment and stay safe from harmful side effects. They looked at seven specific studies published between 1997 and 2026 that focused on patients undergoing leprosy treatment. The researchers were not testing a new drug or a new cure; instead, they were examining the human side of medical care, specifically how a professional who understands the details of medication can guide a patient through a difficult, long-term journey.

The review found that without this extra layer of support, adherence to the treatment is often poor. In one study of 63 patients, fewer than half were taking their medication exactly as prescribed. The main reasons people stopped were the physical toll of the drugs and the psychological weight of the disease. The antibiotics can cause significant side effects, such as severe dryness of the skin, darkening of the skin tone, and changes in the blood that make patients feel weak or sick. Because leprosy already changes the appearance of the skin, these drug-induced changes can be devastating for a patient's self-image, leading them to abandon treatment to avoid further visible changes or because they simply feel too unwell to continue.

When pharmacists stepped in to provide what is called "pharmaceutical care," the results were striking. This approach involves more than just dispensing pills; it includes regular check-ins where the pharmacist listens to the patient, explains what to expect from the medicine, and helps manage side effects before they become unbearable. In one specific study involving 25 patients, every single person had at least one problem related to their medication, such as confusion about when to take a dose or how to handle the side effects. After the pharmacist intervened with personalized advice—such as telling patients to take certain pills with fatty foods to reduce stomach upset or explaining that a reddish tint in urine and sweat is a harmless side effect of one of the drugs—all of these problems were resolved. Most importantly, every single patient in that group continued their treatment until they were cured.

The researchers found that this support works because it addresses the root causes of why people stop taking their medicine. It is not just about forgetting to take a pill; it is about fear, confusion, and the physical discomfort of the treatment. By building a relationship of trust, the pharmacist helps the patient understand that the temporary side effects are a sign the medicine is working, not a reason to quit. This is crucial because stopping treatment prematurely can lead to the bacteria returning and becoming resistant to the drugs, making the disease much harder to treat for everyone. The review highlighted that in many cases, patients were unaware that the darkening of their skin or the fatigue they felt were expected parts of the therapy, and a simple explanation from a knowledgeable professional prevented them from giving up.

The studies also revealed that the healthcare system itself often creates barriers. Patients reported facing stockouts where the medicine was not available, or they struggled with bureaucratic hurdles that made it difficult to get their monthly doses. Pharmacists were found to be essential in navigating these systems, ensuring that patients actually received their medication and that the doses were correct. In some cases, the pharmacist's role expanded to include monitoring for dangerous interactions between the leprosy drugs and other medicines the patient might be taking for different health conditions. This proactive monitoring prevents new health crises from arising while the patient is trying to cure their leprosy.

Ultimately, the review concludes that integrating pharmacists into the primary healthcare team is not just a helpful addition but a vital necessity for curing leprosy. The evidence shows that when a pharmacist actively follows a patient's progress, provides education, and manages side effects, the rate of patients completing their treatment rises significantly. This approach transforms the treatment from a solitary, often frightening task into a supported journey where the patient feels understood and guided. The researchers suggest that for public health systems to truly eliminate leprosy, they must move beyond simply providing free medicine and start providing the human expertise needed to ensure that medicine is taken safely and effectively until the very end.